Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne spatial biology brand, has set a new standard with the development of a next-generation, protease-free RNAscope spatial multiomics workflow.
Advanced Analytics Can Change the Game for Consumer Healthcare Services
Sean Crandell. SVP of Healthcare Economics at MultiPlan Data has become the lifeblood of healthcare, making it possible to gain granular insights that enable more